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Thyroid autoimmunityWe recently reported that, in thyroid cells, ER stress triggered by thapsigargin or tunicamycin, two well
known ER stressing agents, induced dedifferentiation and loss of the epithelial phenotype in rat thyroid cells.
In this study, we sought to evaluate if, in thyroid cells, ER stress could affect MHC class I expression and the
possible implications of this effect in the alteration of function of natural killer cells, suggesting a role in
thyroid pathology. In both, a human line of fetal thyroid cells (TAD-2 cells) and primary cultures of human
thyroid cells, thapsigargin and tunicamicin triggered ER stress evaluated by BiP mRNA levels and XBP-1
splicing. In both cell types, TAD-2 cell line and primary cultures, major histocompatibility complex class I
(MHC-I) plasmamembrane expression was signiﬁcantly reduced by ER stress. This effect was accompanied by
signs of natural killer activation. Thus, natural killer cells dramatically increased IFN-γ production and
markedly increased their cytotoxicity against thyroid cells. Together, these data indicate that ER stress induces
a decrease of MHC class I surface expression in thyroid cells, resulting in reduced natural killer-cell self-
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Major histocompatibility complex class I [MHC-I, also called HLA-I
(human leukocyte antigens) in humans] molecules are cell surface
glycoproteins expressed in virtually all nucleated mammalian cell
types and are crucial in the regulation of cytotoxic effector functions
of natural killer (NK) cells and T cells. MHC-I molecules present,
indeed, antigens to cytotoxic T cells and are part of the recognition
signals that regulate activation of NK cells. Usually antigenic peptides
are generated by proteasomal degradation of cytosolic proteins and
translocated from the cytoplasm to the endoplasmic reticulum (ER)
by the transporter associated with antigen processing (TAP). In the
ER, the assembly of MHC class Iα chain, β2-microglobulin and peptide
is guided by chaperones [1], and antigenic peptides are foundassociated with the chaperones glucose-regulated protein (GRP)94
(GP96), protein disulﬁde isomerase (PDI) and calreticulin [2–6].
Functional class I-peptide complexes are then transported to the cell
surface. A necessary condition for this complex process to occur
properly is that MHC class I heavy chains must be glycosylated and
correctly folded in the endoplasmic reticulum (ER). Failure to
glycosylate or properly fold MHC class I heavy chains results in their
slow or inefﬁcient transport to the cell surface [7–11]. Cellular stress
may result in a decrease of MHC class I expression on the cell surface,
thereby altering the recognition of cells by the adaptive and innate
immune system [12,13].
The single feature uniting different stress stimuli (heat shock,
hypoxia, viral replication, abnormal proteins, starvation or transfor-
mation) is, indeed, that they all ultimately lead to accumulation of
unfolded or misfolded proteins in the lumen of the ER [12,14]. The ER
responds to the accumulation of unfolded proteins by activating
intracellular signal transduction pathways, collectively called the
unfolded protein response (UPR) [15,16]. Activation of these UPR
transducers has pervasive effects on cellular protein economy: (i)
attenuation of protein translation, (ii) increased degradation of ER
proteins by ER associated degradation (ERAD), (iii) transcriptional
activation of genes involved in the folding machinery of the ER and
(iv) increased degradation of ER-localized mRNAs [15].
We hypothesized that protein misfolding and UPR execution may
alter MHC-I plasmamembrane expression and consequently might be
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NK cells is, indeed, their ability to distinguish target cells that differ
only in their expression of MHC class I molecules, leading to the
missing-self recognition by NK cells during the innate immune
response [13]. NK cells can directly lyse target cells [17] and can
also have regulatory roles; for example, they are signiﬁcant early
producers of interferon-γ (IFNγ), which can inﬂuence T-cell
responses [18].
TheNK lymphocytes play amajor role in tissue immune surveillance,
recognizing qualitative and quantitative alterations in the expression of
MHC-I molecules on cells. Such alterations are described in tumors [19]
and in viral infections [20]. However, recently, a role of NK cells in
human autoimmune diseases has been recognized [21]. With regard to
thyroid autoimmunediseases, in spite of thedetailed characterization of
the role of T and B lymphocytes and cytokines [22], scant evidences are
present on the involvement of NK cells.
2. Materials and methods
2.1. Materials
DMEM, FCS, L-glutamine and BSA were from Invitrogen (Paisley,
UK). Thapsigargin (TH) and tunicamycin (TN) were from Sigma-
Aldrich (St. Louis, MO). Anti-MHC class I mAb (W6/32 class I) was
purchased from DAKO (Milan, Italy) and isotype-matched labeled
control was purchased from PharMingen (San Diego, CA).
2.2. Tissues, cell cultures and treatments
Tissue specimens were obtained at surgery from the unaffected
controlateral lobes of thyroid papillary carcinomas or from inter-
nodular tissue of nodular goiters undergoing thyroidectomy. Brieﬂy,
tissues were chopped by scalpels in small pieces and digested by type
IV collagenase (Sigma Chemical Co., St. Louis, MO; 1.25 mg/ml) in
Ham's F-12 medium and 0.5% BSA overnight at 4 °C under rotation.
Cells were pelleted by centrifugation at 150×g for 5 min, washed
twice in BSA-Ham's F-12 medium (BSA/F12), seeded in petri dishes,
and cultured in 5% CO2 atmosphere at 37 °C in Ham's F-12 medium
supplemented with 10% FCS. The medium was changed every 3–
4 days, and the cells to be examined were harvested by treatment
with 0.5 mM EDTA in calcium- and magnesium-free PBS containing
0.05% trypsin (trypsin/PBS). The follicular origin of the cultures was
conﬁrmed by the presence of cytokeratin and thyroglobulin, as
assessed by ﬂow cytoﬂuorometry. The TAD-2 cell line, obtained by
Simian virus 40 infection of human fetal thyroid cells, was a kind gift
of Dr. M. Illario, University of Naples “Federico II” (Naples, Italy). TAD-
2 cells were cultured in a 5% CO2 atmosphere at 37 °C, in DMEM
supplemented with 10% FCS. Medium was changed every 3–4 days.
Cells were detached by 0.5 mMEDTA in calcium- andmagnesium-free
PBS with 0.05% trypsin. TH or TN (Calbiochem) was added to the
medium for 30 min at a ﬁnal concentration of 0.5 μM or 0.5 μg/ml,
respectively. The medium was then replaced with medium without
TH/TN until harvesting, as reported. Alternatively, TH or TNwas left in
the culture medium until harvesting, as reported.
2.3. RNA extraction, northern blot and semiquantitative reverse
transcription-PCR
Total RNAextraction andnorthern blotswere carried out as reported
previously [23]. RNA was reverse transcribed to cDNA by using random
hexamers and the ImProm-II reverse transcriptase system (Promega,
Madison, WI). 10% of the cDNA synthesis reaction was submitted to
semiquantitative PCRanalysis byusingTaqDNApolymerase (Promega).
The following oligonucleotides were used: 5'-GCTTGTGATTGAGAAC-
CAGG and 5'-GAGGCTTGGTGTATATATGG for XBP-1; 5'-ACCACCATG-
GAGAAGG and 5'-CTCAGTGTAGCCCAGGATGC for β-actin.2.4. Preparation of polyclonal NK populations
Polyclonal NK cells were obtained from peripheral blood mono-
nuclear cells (PBMCs), isolated by centrifugation on Lymphoprep
(Nycomed Pharma) gradients from normal donor buffy coats obtained
from the Blood Bank of theMedical School of the Federico II University
of Naples. After separation, the PBMC were washed and incubated in
complete medium, in a horizontally placed plastic ﬂask, for 2 h at
37 °C in order to remove adherent cells. The recovered cells subjected
to a depletion of CD3+ cells by using anti-CD3-coatedmagnetic beads
(Dynal, Oslo, Norway) and a samarium cobalt magnet. The depletion
procedure was repeated twice. Less than 2% of the remaining cells
were CD3+, as assessed by ﬂuorescence-activated cell sorter analysis
(data not shown). The obtained polyclonal NK cells were usedwithout
pre-treatment or incubated for 24 h with 500 IU/ml of human
recombinant IL-2 (IL-2) (Sigma-Aldrich).
2.5. Monoclonal antibodies, immunoﬂuorescence and ﬂow cytometry
Puriﬁed FITC-, PE-, and Cy-chrome-labeledmAb against IFN-γ (4 S.
B3), CD3 (SK7), CD56 (MY31), CD107a (H4A3), MIC A/B (6D4) and
isotype-matched controls were purchased from Becton Dickinson,
(Mountain View, CA). Anti-HLA mAb (W6/32class I) was purchased
from DAKO, Milan, Italy. Immunoﬂuorescence, ﬂow cytometry and
data analysis were performed by FACScalibur apparatus and CellQuest
software (Becton Dickinson, Mountain View, CA), as described [24].
Analysis gates were set such in order to exclude all the debris and
apoptotic cells and to obtain that only viable cells were collected for
the subsequent analysis.
2.6. Cytotoxicity assay
Cytotoxicity was measured using two different methods: (1) the
conventional 4 h 51Cr release assay. Target cells were labeled with Na2
51CrO4 (100 mCi/2 × 106 cells), and the percent of speciﬁc lysis was
calculated as 100 × [(cpm in experimental wells) − (cpm in wells
with target cells alone)]/(total cpm incorporated into target cells). The
spontaneous 51Cr release from target cells cultured alone was
consistently less than 20% of the total cpm; (2) the evaluation of
CD107a expression on NK effectors by using immune ﬂuorescence and
ﬂow cytometry analysis, as described [25,26]. The expression of
CD107a on the membrane of effector cells has been shown to ﬁnely
correlate with target cell lysis, as compared with the classical 51Cr-
release assay [25,26] and it has been largely used as reliable marker
for NK-mediated cytotoxicity [27]. This assay was used with primary
normal human thyroid cells, in which the number of available cells
was low (primary cells grow slowly and for a limited number of cell
divisions). Moreover, the use of this assay allowed the simultaneous
evaluation of interferon-γ (see next paragraph) and of the killing
phenotype of NK effectors. Brieﬂy, the polyclonal IL-2 activated NK
effectors were stained with PE-conjugated anti-CD107a (BD) and
incubated for 6 h, in a round bottomed microtiter plate (Falcon), with
the appropriate cell line target by an effector/target (E/T) ratio of 1:1.
After 1 h of stimulation, Brefeldin-A (5 μg/ml, Sigma Chem. Co., St.
Louis, MO) was added. After the 6-h culture, the cells were stained as
described in the Detection of intracellular IFN-γ paragraph.
2.7. Detection of intracellular IFN-γ
Resting or IL-2-activated polyclonal NK cells (2×105) and TAD-2 or
primary human thyroid cells, used as stimulators, were mixed at a ratio
of 1:1 and incubated in a sterile 96-well plate (Falcon, Seattle,WA) for a
6 h period at 37 °C in RPMI 1640medium and 10% FCS. In order to avoid
any interference mediated by residual IL-2, the effectors were washed
twicewith completemediumbefore the co-culture. In order to promote
intracellular cytokine retention, Brefeldin-A (5 μg/ml, Sigma-Aldrich)
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detected by using triple staining technique (FITC-conjugated anti-CD56,
PE-Cy5-labeled anti-CD3 and APC-conjugated anti-Interferon gamma)
andﬂowcytometry analysis. Brieﬂy, after the incubation the culturewas
harvested, the cells were ﬁxed, and permeabilised by using a cytokine
staining kit, following the manufacturer's instructions (Caltag Labora-
tories, Burlingame, CA). A live gatewas set such that only the NKCD56+
lymphocytes were collected for analysis. In selected experiments, the
staining for CD107a and IFN-γ on NK effectors was performed in the
same experimental condition (see previous paragraph).
2.8. Statistical procedures
Data were analyzed with Statview software (Abacus Concepts) by
one-factor analysis of variance. p values of less than 0.05 were
considered statistically signiﬁcant.
3. Results
3.1. Thapsigargin (TH) and tunicamycin (TN) activate the UPR in both
TAD-2 and primary thyroid cells
As a ﬁrst step, we set up the experimental conditions able to cause
UPR activation in the ER of both TAD-2 and primary thyroid cells. ToFig. 1. Thapsigargin (TH) and tunicamycin (TN) induce ER stress in both TAD-2 and primary
TAD-2 cells. Northern blot analysis of total RNA extracted from cells vehicle treated (Contr
without TH or TN. GAPDH was analyzed on the same ﬁlters. The intensity of the band corre
arbitrary units and represent the average+1 SD of three different experiments. The asterisks
XBP-1 and β-actin of the same total RNAs used in (A left panel). (B) Left panel: TH and TN ind
of total RNA extracted from cells vehicle treated (Control) or treated with 0.5 μM TH or 0.5 μg
on the same ﬁlters. The intensity of the band corresponding to BiP was quantiﬁed by phospho
SD of three different experiments. The asterisks represent statistically signiﬁcant difference
used in (B, left panel).this aim, we tested the effect of the widely used ER stress-inducing
agents TH and TN on the expression levels of the ER stress marker BiP
and the splicing of mRNA encoding XBP-1. In particular, we treated
TAD-2 and primary thyroid cells with a low TH/TN concentration that
we have previously shown [28] to be effective to elicit a mild ER stress
in thyroid cells that does not trigger the activation of apoptosis. We
performed northern blots and RT-PCR assays. As shown in Fig. 1,
treatments of 30 min with TH or TN, followed by 24 h in medium
without TH/TN, increased BiP mRNA, in both TAD-2 (Fig. 1A, left
panel) and primary thyroid cells (Fig. 1B, left panel) by ~6-fold.
Furthermore, we observed an increase in the spliced active form of
XBP-1 mRNA following TH and TN treatments in both TAD-2 (Fig. 1A,
right panel) and primary thyroid cells (Fig. 1B, right panel). The
increase of BiP mRNA and the appearance of the spliced active form of
XBP-1 mRNA was similar when cells where incubated continuously
for 24 h with TH/TN (data not shown).3.2. ER stress affects MHC class I expression in TAD-2 cells
To test the effect of ER stress induction on MHC class I expression,
TAD-2 cells were treated with TH or TN. Cells were incubated for
30 min (burst) with TH (THb) or TN (TNb) and the incubation
medium was then replaced with fresh medium for 24 or 48 h.
Alternatively, TH or TN treatments were left in the culturemedium forthyroid cells. (A) Left panel: TH and TN induce upregulation of mRNA encoding BiP in
ol) or treated with 0.5 μM TH or 0.5 μg/ml TN for 30 min, followed by 24 h in medium
sponding to BiP was quantiﬁed by phosphorimaging, and plotted on a bar graph with
represent statistically signiﬁcant differences (pb0.01). Right panel: RT-PCR analysis for
uce upregulation of mRNA encoding BiP in primary thyroid cells. Northern blot analysis
/ml TN for 30 min, followed by 24 h in mediumwithout TH or TN. GAPDHwas analyzed
rimaging and plotted on a bar graph with arbitrary units and represent the average+1
s (pb0.01). Right panel: RT-PCR analysis for XBP-1 and β-actin of the same total RNAs
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by ﬂow cytometry using antibodyW6/32 that detects MHC (HLA)-A, B
and Cmolecules. Mean and SD of themean intensity of ﬂuorescence of
cells treated or not with TN and TH are shown (Fig. 2A and B,
respectively, n=3). Both, continuative or burst treatments with TN
and TH induced a signiﬁcant (pb0.01) downregulation of MHC-I
expression at both 24 and 48 h. Interestingly, a greater efﬁcacy of TN
in decreasing MHC-I expression (Fig. 2A and B) was paralleled by a
greater ability of TN to affect the splicing of XBP-1 (Fig. 1). In Fig. 2 C is
shown a representative experiment with TN.3.3. Increased cytotoxic activity of NK incubated with TAD-2 cells
undergoing ER stress
Since NK cells are potent killers, particularly of cells with reduced
MHC-I expression [29,30] we investigated the susceptibility of TAD-2
cells, undergoing ER stress, to be lysed by NK cells. To this aim, TAD-2
cells have been treated with TH for 30 min followed by 24 h in
medium without TH. Then, IL-2 activated polyclonal NK, obtained as
outlined in Materials and methods, were incubated with TAD-2 cellsFig. 2. TN and TH induce a decrease ofMHC-I surface expression in TAD-2 cells. (A) TAD-2 cel
with 0.5 μg/ml TN and then the mediumwas replaced with fresh medium for 24 or 48 h (24b
MHC class I molecules was tested by ﬂow cytometry usingmAbW6/32 speciﬁc for MHC (HLA
**, pb0.01. (B) TAD-2 cells were either treated continuously with 0.5 μM TH for 24 or 48 h
medium for 24 or 48 h (24b or 48b). At the indicated time points, cells were harvested and c
W6/32 speciﬁc for MHC (HLA)-A, -B, -C. Mean and SD of the mean intensity of ﬂuorescenc
independent experiments with TN. Analysis gates were set such in order to exclude all th
subsequent analysis.for 4 h. As shown in Fig. 3, polyclonal NK cells incubated with TAD-2
cells previously treated with TH displayed a signiﬁcantly (pb0.01)
increased cytotoxic capacity, when compared to NK cells incubated
with untreated TAD-2 cells. When resting (not IL-2 stimulated) NK
cells were used, the increased cytotoxicity of NK cells towards ER
stressed respect to unstressed TAD-2 cells was still present, albeit the
absolute values were, as expected, lower (not shown). This result
suggests that ER stress increases susceptibility of thyroid cells to NK-
mediated killing.3.4. Increased IFN-γ producing NK cells when incubated with TAD-2 cells
undergoing ER stress
Besides their capability to lyse target cells, NK cells are also
signiﬁcant early producers of IFN-γ. Therefore, to extend a positive
role of ER stress and reduced MHC-I expression on the increased
activity of NK cells, we investigated IFN-γ production. As above, IL-2
stimulated NK cells were incubated for 6 h with TAD-2 cells
previously treated or not with TH or TN for 30 min followed by
24 h in mediumwithout TH/TN. As shown in Fig. 4, the percentage ofls were either treated continuously with 0.5 μg/ml TN for 24 or 48 h or treated for 30 min
or 48b). At the indicated time points, cells were harvested and cell surface expression of
)-A, -B, -C. Mean and SD of themean intensity of ﬂuorescence of cells are shown (n=3).
or treated for 30 min with 0.5 μM TH and then the medium was replaced with fresh
ell surface expression of MHC class I molecules was tested by ﬂow cytometry using mAb
e of cells are shown (n=3). **pb0.01. (C) Data are representative of one out of three
e debris and apoptotic cells and to obtain that only viable cells were collected for the
5:1 10:1 20:1 40:1 80:1
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Fig. 3. ER stress signiﬁcantly affects the NK lytic efﬁciency against TAD-2 cells. TAD-2
cells were treated for 30 min with 0.5 μM TH and then the medium was replaced with
fresh medium for 24 or 48 h. Human IL-2 activated polyclonal NK cells were then used
as effectors in a conventional 4 h 51Cr release cytotoxicity assay against untreated
(control) or treated (TH) TAD-2 cells. The percentage of lysis and E :T ratio was reported
on the abscissas and ordinate axes, respectively. Data are reported as means of the
results from three independent experiments. Standard deviations for each E/T ratio are
indicated as error bars (pb0.01).
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both TH and TN treatments when compared to untreated cells.
Analogously to the cytotoxicity assays, the increased IFN-γ produc-
tion caused by ER stressed TAD-2 cells was conﬁrmed with resting
NK cells, albeit with lower absolute values (not shown). These
results show that interaction of NK cells with ER stressed thyroid
cells increased not only cytotoxic activity but also cytokine
production of NK cells.%
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Fig. 4. Increased IFN-γ producing NK cells when incubated with TAD-2 cells
undergoing ER stress. TAD-2 cells were treated for 30 min with 0.5 μM TH or 0.5 μg/
ml TN and then the medium was replaced with fresh medium for 24 h. Then, TAD-2
cells were incubated with IL-2 activated polyclonal NK cells for a 6 h period. The
ﬂow cytometry analysis for the intracellular IFN-γ staining in NK cells is reported.
Cells were stained with ﬂuorescein isothiocyanate anti-IFN-γ monoclonal anti-
bodies (mAbs). Mean and SD of the mean intensity of ﬂuorescence of cells are
shown (n=3). **pb0.01.3.5. Decreased MHC-I surface expression by ER stress in primary thyroid
cells and increased cytotoxic activity and IFN-γ production of NK cells
incubated with primary thyroid cells undergoing ER stress
To strengthen the results obtained in TAD-2 cells, we decided to
reproduce some of the above-mentioned experiments in proliferating
primary normal human thyroid cells. As shown in Fig. 5A and B,
similarly to TAD-2 cells, primary normal human thyroid cells treated
for 30 min with TN and TH followed by 24 h incubation in TN/TH-free
medium, showed a marked reduction of MHC-I surface expression
(pb0.01), as evidenced by ﬂow cytometry experiments.
In addition, this effect was accompanied by a signiﬁcant increase
(pb0.01) of the percentage of IFN-γ producing NK when primary
human thyroid cells were treated with TN and TH and then incubated
for 6 h with IL-2 activated polyclonal NK obtained as outlined in
Materials and Methods (Fig. 6A and B). As with TAD-2 cells, similar
results were obtained with resting NK cells, albeit, as expected,
quantitatively lower (not shown).
To investigate the cytotoxic activity of NK cells when challenged
with primary human thyroid cells, we took advantage of the recent
assay of CD107a expression [29,30]. As shown in Fig. 6 C the
expression of CD107a increased by 60% when NK cells were
challenged with ER stressed primary cells respect to a challenge
with unstressed primary cells. Of note, the increased expression of
CD107a and increased production of IFN-γ were simultaneously
evaluated in the same experiments.
Together these results suggest that ER stress downregulates MHC-I
surface expression and NK-dependent self-tolerance also in normal
human thyroid cells.
3.6. TH did not change the expression of stress-induced soluble major
histocompatibility complex class I-related chains A/B (MIC A/B)
TheMHC-I homologs,MICA/B, are described as activating ligands for
the NK cell receptor NKG2D in human [31]. These stress-induced
ligands appear able to induceNK cells by NKG2D engagement, andwere
described to be increased in various chronic diseases [31,32]. In order to
ascertain if the cytotoxic NK phenotype against TH-treated thyroid cells
could be dependent also on the increase of stress-induced ligands, we
tested the effect of the drug in primary cells. As shown in Fig. 6D, the
expression ofMIC A/B on TH-treated primary thyroid cells appears to be
unmodiﬁed. This result point to exclude a role for increased activating
NK-Ligands on NK cytotoxicity toward drug-treated thyroid cells,
underscoring the role played by MHC-I down-regulation.
4. Discussion
The ER provides the machinery to assist protein folding and to
assure that only correctly folded proteins can move on along the
secretory pathway. Many disturbances, including perturbation of
calcium homeostasis or redox status, increased cargo protein
synthesis or/and altered glycosylation, result in accumulation of
unfolded proteins in the lumen and trigger the unfolded protein
response (UPR). Elucidation of the mechanisms governing ER stress
signaling has linked this response to the regulation of diverse
physiologic processes as well as to the progression of a number of
diseases, such as diabetes, cystic ﬁbrosis, Alzheimer disease and
cancer. We have shown that perturbing the endoplasmic reticulum
homeostasis of rat thyroid cell lines alter the folding pathway of
thyroglobulin [33–38], the major biosynthetic product of thyrocytes,
leading to ER stress and UPR activation [28,39]. We have also shown
that, in these conditions, thyroid cells execute a dedifferentiation
program, involving tissue-speciﬁc proteins and epithelial tissue
differentiation and organization [28]. We hypothesized that ER stress
could affect another important process in thyroid cells, that is, MHC-I
surface expression. This, might, in turn, affect NK function. In this
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Fig. 5. Decreased MHC-I surface expression by ER stress in primary thyroid cells. Primary human thyroid cells were treated for 30 min with 0.5 μg/ml TN (A) or 0.5 μM TH (B) and
then the mediumwas replaced with fresh medium for 24 h. Then, cells were harvested and cell surface expression of MHC class I molecules was tested by ﬂow cytometry using mAb
W6/32 speciﬁc for MHC (HLA)-A, -B, -C. Mean and SD of the mean intensity of ﬂuorescence of cells are shown (n=3). **pb0.01. Analysis gates were set such in order to exclude all
the debris and apoptotic cells and to obtain that only viable cells were collected for the subsequent analysis.
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differentiation, ER stress, induced by TH/TN, negatively affects surface
expression of MHC-I proteins. Furthermore, we show that ER stress-
induced downregulation of MHC-I was accompanied by increased NK
activation, monitored by increased cytotoxic activity and increased
production of IFN-γ.
It is well known that an important feature of NK cells is their ability
to distinguish target cells that differ only in their expression of MHC
class I molecules. The recognition and lysis of MHC class I low target
cells by NK cells is aptly referred to as missing-self recognition [40].
This recognition occurs frequently in virus-infected and cancer cells
[40]. It is thought that the downregulation of MHC class I molecules by
virus-infected cells is a strategy to evade cytolysis by CD8+ T cells and
that missing-self recognition by NK cells is a counter-response by the
immune system. Importantly, viral infection or transformation of
target cells does not seem to be a prerequisite for missing-self
recognition. Even untransformed, uninfected target cells can be lysed
by NK cells if the target cells fail to express a full complement of
normal self MHC class I proteins [41]. This may well be the case of
stressed normal cells, when the stress is able to reduce surface
expression of MHC-I molecules. We have shown a similar occurrence
in thyroid cells experiencing ER stress. However, missing-self
recognition may operate in conjunction with stimulatory recognition.
To lyse target cells or to produce effector cytokines, NK cells, similar to
T cells, may be triggered by stimulatory receptors [41].We have begun
to address this possibility by evaluating the expression of MICA/B,
activating ligands for the NK cell receptor NKG2D [31], on ER stressed
primary thyroid cells. We detected no variations on MICA/B following
ER stress, and this result underscores the role played by MHC-I down-
regulation. Of course, this result does not exclude that other activating
ligands may be involved.
Interestingly, a link between ER stress, decreased MHC-I expres-
sion and immunological anomalies is suggested by recent ﬁndings on
haemochromatosis, an inherited autosomic recessive disease of iron
metabolism characterized by an increased intestinal iron absorption
that leads to iron overload of several organs and to immunological
anomalies [42,43]. The expression of the mutated HFE (the genetic
defect in haemochromatosis) triggers an UPR and decreases MHC-I
surface expression in 293 T cells [44].
Recently, a role of NK cells in human autoimmune diseases has
been recognized [21]. In several cases, an activated NK phenotype
secondary to KIR (activating receptors of NK cells)-MHC-I genotypes
has been found in human autoimmune diseases. For example,
scleroderma and rheumatoid arthritis are associated with thepresence of activating KIR2DS2 [45,46]. However, with regard to
thyroid autoimmune diseases, in spite of the detailed characterization
of the role of T and B lymphocytes and cytokines [22], scant evidences
are present on the involvement of NK cells. Thus, it is know that
thyroid cells from patients with autoimmune thyroid diseases but not
from healthy controls upregulate MHC-II expression [47,48] and that
MHC-I and TAP are overexpressed in autoimmune thyroid diseases
but not in normal glands [47,49]. These results suggest a more
efﬁcient priming of TCD4+ and TCD8+ cells in response to
autoantigens. The key cytokine involved in these alterations was
IFN-γ, either in vitro [50,51] and in vivo [52].
Apparently in contrast with these consolidated ﬁndings, our data,
indicating a critical role for ER stress in decreasing MHC-I molecules
and in regulating bothNK cytotoxicity and IFN-γ production in thyroid
cells, may support a role of NK cells in autoimmune thyroid diseases.
However, the role in thyroid autoimmunity of NK and of TCD4+
and TCD8+ cells, sustained by a downregulation or upregulation of
MHC-I, respectively, may be only apparently in contrast and not
mutually exclusive. NK cells may be activated early in the autoim-
mune response, by MHC-I downregulation on thyroid cells, and may
start to damage them and to produce IFN-γ. Interestingly, viral
infections (that are vaguely associated with autoimmunity) are able
to cause ER stress, and other environmental factors of thyroid
autoimmunity [53], may also be able to cause ER stress and MHC-I
downregulation. This may lead to IFN-γ-driven increased MHC-I,
MHC-II and TAP expression on thyroid cells. Then, a more efﬁcient
priming of TCD4+ and TCD8+ cells will play a role in autoimmune
disease progression.
Interestingly, increased [54], unchanged [55], and decreased [56]
NK activity have been reported in thyroid autoimmune diseases,
raising the possibility that in these reports different stages of the
diseases may have been analyzed.
Besides thyroid autoimmunity ER stress-induced MHC-I down-
regulation may be present in thyroid cancers, affecting the immune
response toward cancer cells. We plan to pursue this additional aspect
of our ﬁndings.
Moreover, in the case described here, an activated NK phenotype is
not secondary to cell surface modiﬁcations of NK cells [45,46], but to
modiﬁcations of the target cells, a mechanism particularly relevant for
organ-speciﬁc autoimmune diseases. Thus, a better understanding of
the connection of the UPR with autoimmune thyroid diseases,
including its role in MHC-I antigen presentation pathway and possible
implications for new clinical approaches, deserves to be further
investigated.
Fig. 6. Increased IFN-γ production and CD107a expression of NK cells incubated with primary thyroid cells undergoing ER stress. Unchanged expression of MICA/B in primary thyroid
cells undergoing ER stress. Primary human thyroid cells were treated for 30 min with 0.5 μMTN (A) or 0.5 μMTH (B) and then the mediumwas replaced with fresh medium for 24 h.
Then, cells were incubated with IL-2 activated polyclonal NK cells for a 6-h period. The ﬂow cytometry analysis for the intracellular IFN-γ staining in NK is reported. Cells were
stained with ﬂuorescein isothiocyanate anti-IFN-γ monoclonal antibodies (mAbs). Mean and SD of the mean intensity of ﬂuorescence of cells are shown (n=3). **pb0.01.
(C) Primary human thyroid cells were treated for 30 min with 0.5 μM TH and then the medium was replaced with fresh medium for 24 h. Then, cells were incubated with IL-2
activated polyclonal NK cells for a 6-h period and cell surface expression of CD107a molecules was tested by ﬂow cytometry using PE-conjugated anti-CD107a antibodies. Mean and
SD of the mean intensity of ﬂuorescence of cells are shown (n=3). **pb0.01. (D) Primary human thyroid cells were treated for 30 min with 0.5 μM TH and then the medium was
replaced with fresh medium for 24 h. Then, cells were harvested and cell surface expression of MICA/B molecules was tested by ﬂow cytometry using anti-MICA/B 6D4 antibodies.
Mean and SD of the mean intensity of ﬂuorescence of cells are shown (n=3). **pb0.01.
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